Utility of a Mobile Application for Young Women With Breast Cancer
NCT ID: NCT07009093
Last Updated: 2026-01-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
120 participants
INTERVENTIONAL
2026-03-31
2030-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Feasibility of Integrating the Outcomes4Me Smartphone Navigation Application Into the Care Management of Breast Cancer Patients
NCT04262518
Interventions to Increase Screening by Breast Cancer Survivors and Their High Risk Female Relatives
NCT01612338
mHealth Behavioural Intervention to Increase Breast Cancer Screening Rates Among Members of the Public
NCT06293508
Breast Health Education for Underserved Latino Women
NCT02205736
Investigation of a Digital Healthy Habits Program for Individuals With Breast Cancer
NCT04967209
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Access to the Mighty Pro Application
Participants will be given access to the Mighty Pro Application for 12 months.
Mighty Pro Application
Access to Mighty Pro Application
No Access to the Mighty Pro Application
Participants will not be given access to the Mighty Pro Application.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Mighty Pro Application
Access to Mighty Pro Application
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age ≥ 18 and ≤ 45 years at the time of consent
* Female
* Established patient at Atrium Health Wake Forest Baptist Comprehensive Cancer Center (AHWFBCCC)
* Histological confirmation of any type and stage (0-IV) of breast cancer
* Screening (baseline) NCCN Distress Thermometer score ≥ 4
* Access to a mobile device for trial purposes and an active email address
* Ability to read and understand the English language. NOTE: The Mighty Pro Application is available in English only.
* As determined by the enrolling Investigator, ability of the participant to understand and comply with study procedures for the entire length of the study
Exclusion Criteria
18 Years
45 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Atrium Health Levine Cancer Institute
OTHER
Wake Forest University Health Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lejla Hadzikadic-Gusic, MD
Role: PRINCIPAL_INVESTIGATOR
Wake Forest University Health Sciences
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Atrium Health Levine Cancer
Charlotte, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ONC-BRST-2401
Identifier Type: OTHER
Identifier Source: secondary_id
IRB00119070
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.